SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: David Howe who wrote (1306)10/20/1998 7:34:00 AM
From: BMcV  Read Replies (1) | Respond to of 10280
 
Schering reports earnings.

Of especial interest: "In the 1998 third quarter, the CLARITIN line, the world's No. 1 antihistamine, recorded worldwide sales of $635 million, up 42 percent."

biz.yahoo.com

It looks like Claritin could be a $3 billion drug by the time SEPR get in.